Sweden
MedTech Concept aims to revolutionize the medical device industry with its groundbreaking product, Minipen 2, the world's smallest injection device. The company addresses the inconvenience of existing devices for insulin injections, and plans to introduce the compact Minipen to various markets, catering to individuals with Type 1 and 2 diabetes, cosmetic markets, medical vaccination and immunization programs, as well as veterinary use.
Founded in 2019 and headquartered in Sweden, the company is on the brink of commencing Minipen production in August 2021, subject to securing financing in January 2021. With an impressive list of 15 potential clients showing interest and two distributors already on board, MedTech Concept is poised for significant growth.
Seeking trade finance to fund 12 months of operating expenses and capital expenditures, the company offers opportunities for small investors to obtain shares in the Swedish company and corporate entities to support via a private placement offer for a convertible loan, offering potential for equity/stock conversion at a mutually agreed upon price after two years.
MedTech Concept presents an innovative and promising investment opportunity at the forefront of the MedTech industry, with potential for global impact and substantial returns for investors.
